Anticorpi anti-proteine citrullinate (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Anticorpi anti-proteine citrullinate" in Italian language version.

refsWebsite

Global rank Italian rank

13nih.gov

4^th place

9^th place

13doi.org

2^nd place

7^th place

9oadoi.org

799^th place

22^nd place

doi.org

dx.doi.org

Puszczewicz M, Iwaszkiewicz C, Role of anti-citrullinated protein antibodies in diagnosis and prognosis of rheumatoid arthritis, in Arch Med Sci, vol. 7, n. 2, Aprile 2011, pp. 189–94, DOI:10.5114/aoms.2011.22067, PMC 3258718, PMID 22291756. URL consultato il 12 aprile 2021.
Raptopoulou A, Sidiropoulos P, Katsouraki M, Boumpas DT, Anti-citrulline antibodies in the diagnosis and prognosis of rheumatoid arthritis: evolving concepts, in Crit Rev Clin Lab Sci, vol. 44, n. 4, 2007, pp. 339–63, DOI:10.1080/10408360701295623, PMID 17558653. URL consultato il 12 aprile 2021.
Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, Ménard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, Tak PP, Upchurch KS, Vencovsky J, Wolfe F, Hawker G, 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative, in Ann Rheum Dis, vol. 69, n. 9, Settembre 2010, pp. 1580–8, DOI:10.1136/ard.2010.138461, PMID 20699241. URL consultato il 12 aprile 2021.
Young BJ, Mallya RK, Leslie RD, Clark CJ, Hamblin TJ, Anti-keratin antibodies in rheumatoid arthritis, in Br Med J, vol. 2, n. 6182, Luglio 1979, pp. 97–9, DOI:10.1136/bmj.2.6182.97, PMC 1596039, PMID 111762. URL consultato il 12 aprile 2021.
Sebbag M, Simon M, Vincent C, Masson-Bessière C, Girbal E, Durieux JJ, Serre G, The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies, in J Clin Invest, vol. 95, n. 6, Giugno 1995, pp. 2672–9, DOI:10.1172/JCI117969, PMC 295950, PMID 7539459. URL consultato il 12 aprile 2021.
Vossenaar ER, Després N, Lapointe E, van der Heijden A, Lora M, Senshu T, van Venrooij WJ, Ménard HA, Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin, in Arthritis Res Ther, vol. 6, n. 2, 2004, pp. R142–50, DOI:10.1186/ar1149, PMC 400433, PMID 15059278. URL consultato il 12 aprile 2021.
Pratesi F, Tommasi C, Anzilotti C, Chimenti D, Migliorini P, Deiminated Epstein-Barr virus nuclear antigen 1 is a target of anti-citrullinated protein antibodies in rheumatoid arthritis, in Arthritis Rheum, vol. 54, n. 3, Marzo 2006, pp. 733–41, DOI:10.1002/art.21629, PMID 16508937. URL consultato il 12 aprile 2021.
Bang H, Egerer K, Gauliard A, Lüthke K, Rudolph PE, Fredenhagen G, Berg W, Feist E, Burmester GR, Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis, in Arthritis Rheum, vol. 56, n. 8, Agosto 2007, pp. 2503–11, DOI:10.1002/art.22817, PMID 17665451. URL consultato il 12 aprile 2021.
Nishimura K, Sugiyama D, Kogata Y, Tsuji G, Nakazawa T, Kawano S, Saigo K, Morinobu A, Koshiba M, Kuntz KM, Kamae I, Kumagai S, Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis, in Ann Intern Med, vol. 146, n. 11, Giugno 2007, pp. 797–808, DOI:10.7326/0003-4819-146-11-200706050-00008, PMID 17548411. URL consultato il 12 aprile 2021.
Anzilotti C, Riente L, Pratesi F, Chimenti D, Delle Sedie A, Bombardieri S, Migliorini P, IgG, IgA, IgM antibodies to a viral citrullinated peptide in patients affected by rheumatoid arthritis, chronic arthritides and connective tissue disorders, in Rheumatology (Oxford), vol. 46, n. 10, Ottobre 2007, pp. 1579–82, DOI:10.1093/rheumatology/kem193, PMID 17717033. URL consultato il 12 aprile 2021.
Coenen D, Verschueren P, Westhovens R, Bossuyt X, Technical and diagnostic performance of 6 assays for the measurement of citrullinated protein/peptide antibodies in the diagnosis of rheumatoid arthritis, in Clin Chem, vol. 53, n. 3, Marzo 2007, pp. 498–504, DOI:10.1373/clinchem.2006.078063, PMID 17259232. URL consultato il 12 aprile 2021.
van Gaalen F, Ioan-Facsinay A, Huizinga TW, Toes RE, The devil in the details: the emerging role of anticitrulline autoimmunity in rheumatoid arthritis, in J Immunol, vol. 175, n. 9, Novembre 2005, pp. 5575–80, DOI:10.4049/jimmunol.175.9.5575, PMID 16237041. URL consultato il 12 aprile 2021.
Greiner A, Plischke H, Kellner H, Gruber R, Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis, in Ann N Y Acad Sci, vol. 1050, Giugno 2005, pp. 295–303, DOI:10.1196/annals.1313.031, PMID 16014545. URL consultato il 12 aprile 2021.

nih.gov

ncbi.nlm.nih.gov

Puszczewicz M, Iwaszkiewicz C, Role of anti-citrullinated protein antibodies in diagnosis and prognosis of rheumatoid arthritis, in Arch Med Sci, vol. 7, n. 2, Aprile 2011, pp. 189–94, DOI:10.5114/aoms.2011.22067, PMC 3258718, PMID 22291756. URL consultato il 12 aprile 2021.
Raptopoulou A, Sidiropoulos P, Katsouraki M, Boumpas DT, Anti-citrulline antibodies in the diagnosis and prognosis of rheumatoid arthritis: evolving concepts, in Crit Rev Clin Lab Sci, vol. 44, n. 4, 2007, pp. 339–63, DOI:10.1080/10408360701295623, PMID 17558653. URL consultato il 12 aprile 2021.
Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, Ménard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, Tak PP, Upchurch KS, Vencovsky J, Wolfe F, Hawker G, 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative, in Ann Rheum Dis, vol. 69, n. 9, Settembre 2010, pp. 1580–8, DOI:10.1136/ard.2010.138461, PMID 20699241. URL consultato il 12 aprile 2021.
Young BJ, Mallya RK, Leslie RD, Clark CJ, Hamblin TJ, Anti-keratin antibodies in rheumatoid arthritis, in Br Med J, vol. 2, n. 6182, Luglio 1979, pp. 97–9, DOI:10.1136/bmj.2.6182.97, PMC 1596039, PMID 111762. URL consultato il 12 aprile 2021.
Sebbag M, Simon M, Vincent C, Masson-Bessière C, Girbal E, Durieux JJ, Serre G, The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies, in J Clin Invest, vol. 95, n. 6, Giugno 1995, pp. 2672–9, DOI:10.1172/JCI117969, PMC 295950, PMID 7539459. URL consultato il 12 aprile 2021.
Vossenaar ER, Després N, Lapointe E, van der Heijden A, Lora M, Senshu T, van Venrooij WJ, Ménard HA, Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin, in Arthritis Res Ther, vol. 6, n. 2, 2004, pp. R142–50, DOI:10.1186/ar1149, PMC 400433, PMID 15059278. URL consultato il 12 aprile 2021.
Pratesi F, Tommasi C, Anzilotti C, Chimenti D, Migliorini P, Deiminated Epstein-Barr virus nuclear antigen 1 is a target of anti-citrullinated protein antibodies in rheumatoid arthritis, in Arthritis Rheum, vol. 54, n. 3, Marzo 2006, pp. 733–41, DOI:10.1002/art.21629, PMID 16508937. URL consultato il 12 aprile 2021.
Bang H, Egerer K, Gauliard A, Lüthke K, Rudolph PE, Fredenhagen G, Berg W, Feist E, Burmester GR, Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis, in Arthritis Rheum, vol. 56, n. 8, Agosto 2007, pp. 2503–11, DOI:10.1002/art.22817, PMID 17665451. URL consultato il 12 aprile 2021.
Nishimura K, Sugiyama D, Kogata Y, Tsuji G, Nakazawa T, Kawano S, Saigo K, Morinobu A, Koshiba M, Kuntz KM, Kamae I, Kumagai S, Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis, in Ann Intern Med, vol. 146, n. 11, Giugno 2007, pp. 797–808, DOI:10.7326/0003-4819-146-11-200706050-00008, PMID 17548411. URL consultato il 12 aprile 2021.
Anzilotti C, Riente L, Pratesi F, Chimenti D, Delle Sedie A, Bombardieri S, Migliorini P, IgG, IgA, IgM antibodies to a viral citrullinated peptide in patients affected by rheumatoid arthritis, chronic arthritides and connective tissue disorders, in Rheumatology (Oxford), vol. 46, n. 10, Ottobre 2007, pp. 1579–82, DOI:10.1093/rheumatology/kem193, PMID 17717033. URL consultato il 12 aprile 2021.
Coenen D, Verschueren P, Westhovens R, Bossuyt X, Technical and diagnostic performance of 6 assays for the measurement of citrullinated protein/peptide antibodies in the diagnosis of rheumatoid arthritis, in Clin Chem, vol. 53, n. 3, Marzo 2007, pp. 498–504, DOI:10.1373/clinchem.2006.078063, PMID 17259232. URL consultato il 12 aprile 2021.
van Gaalen F, Ioan-Facsinay A, Huizinga TW, Toes RE, The devil in the details: the emerging role of anticitrulline autoimmunity in rheumatoid arthritis, in J Immunol, vol. 175, n. 9, Novembre 2005, pp. 5575–80, DOI:10.4049/jimmunol.175.9.5575, PMID 16237041. URL consultato il 12 aprile 2021.
Greiner A, Plischke H, Kellner H, Gruber R, Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis, in Ann N Y Acad Sci, vol. 1050, Giugno 2005, pp. 295–303, DOI:10.1196/annals.1313.031, PMID 16014545. URL consultato il 12 aprile 2021.

oadoi.org

Raptopoulou A, Sidiropoulos P, Katsouraki M, Boumpas DT, Anti-citrulline antibodies in the diagnosis and prognosis of rheumatoid arthritis: evolving concepts, in Crit Rev Clin Lab Sci, vol. 44, n. 4, 2007, pp. 339–63, DOI:10.1080/10408360701295623, PMID 17558653. URL consultato il 12 aprile 2021.
Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, Ménard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, Tak PP, Upchurch KS, Vencovsky J, Wolfe F, Hawker G, 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative, in Ann Rheum Dis, vol. 69, n. 9, Settembre 2010, pp. 1580–8, DOI:10.1136/ard.2010.138461, PMID 20699241. URL consultato il 12 aprile 2021.
Pratesi F, Tommasi C, Anzilotti C, Chimenti D, Migliorini P, Deiminated Epstein-Barr virus nuclear antigen 1 is a target of anti-citrullinated protein antibodies in rheumatoid arthritis, in Arthritis Rheum, vol. 54, n. 3, Marzo 2006, pp. 733–41, DOI:10.1002/art.21629, PMID 16508937. URL consultato il 12 aprile 2021.
Bang H, Egerer K, Gauliard A, Lüthke K, Rudolph PE, Fredenhagen G, Berg W, Feist E, Burmester GR, Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis, in Arthritis Rheum, vol. 56, n. 8, Agosto 2007, pp. 2503–11, DOI:10.1002/art.22817, PMID 17665451. URL consultato il 12 aprile 2021.
Nishimura K, Sugiyama D, Kogata Y, Tsuji G, Nakazawa T, Kawano S, Saigo K, Morinobu A, Koshiba M, Kuntz KM, Kamae I, Kumagai S, Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis, in Ann Intern Med, vol. 146, n. 11, Giugno 2007, pp. 797–808, DOI:10.7326/0003-4819-146-11-200706050-00008, PMID 17548411. URL consultato il 12 aprile 2021.
Anzilotti C, Riente L, Pratesi F, Chimenti D, Delle Sedie A, Bombardieri S, Migliorini P, IgG, IgA, IgM antibodies to a viral citrullinated peptide in patients affected by rheumatoid arthritis, chronic arthritides and connective tissue disorders, in Rheumatology (Oxford), vol. 46, n. 10, Ottobre 2007, pp. 1579–82, DOI:10.1093/rheumatology/kem193, PMID 17717033. URL consultato il 12 aprile 2021.
Coenen D, Verschueren P, Westhovens R, Bossuyt X, Technical and diagnostic performance of 6 assays for the measurement of citrullinated protein/peptide antibodies in the diagnosis of rheumatoid arthritis, in Clin Chem, vol. 53, n. 3, Marzo 2007, pp. 498–504, DOI:10.1373/clinchem.2006.078063, PMID 17259232. URL consultato il 12 aprile 2021.
van Gaalen F, Ioan-Facsinay A, Huizinga TW, Toes RE, The devil in the details: the emerging role of anticitrulline autoimmunity in rheumatoid arthritis, in J Immunol, vol. 175, n. 9, Novembre 2005, pp. 5575–80, DOI:10.4049/jimmunol.175.9.5575, PMID 16237041. URL consultato il 12 aprile 2021.
Greiner A, Plischke H, Kellner H, Gruber R, Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis, in Ann N Y Acad Sci, vol. 1050, Giugno 2005, pp. 295–303, DOI:10.1196/annals.1313.031, PMID 16014545. URL consultato il 12 aprile 2021.